Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04626518
Title Substudy 03B: A Study of Immune and Targeted Combination Therapies in Participants With Second Line Plus (2L+) Renal Cell Carcinoma (MK-3475-03B)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Merck Sharp & Dohme Corp.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | NZL | NLD | ISR | HUN | GBR | FRA | ESP | CAN | AUS

Facility Status City State Zip Country Details
University of California at San Francisco ( Site 3008) San Francisco California 94158 United States Details
Yale-New Haven Hospital-Yale Cancer Center ( Site 3011) New Haven Connecticut 06510 United States Details
University of Chicago ( Site 3013) Chicago Illinois 60637 United States Details
University of Iowa ( Site 3012) Iowa City Iowa 52242 United States Details
Henry Ford Health System ( Site 3014) Detroit Michigan 48202 United States Details
Laura and Isaac Perlmutter Cancer Center ( Site 3016) New York New York 10016 United States Details
Memorial Sloan Kettering Cancer Center ( Site 3002) New York New York 10065 United States Details
Duke Cancer Institute ( Site 3015) Durham North Carolina 27710 United States Details
UPMC Cancer Center/Hillman Cancer Center ( Site 3017) Pittsburgh Pennsylvania 15232 United States Details
Vanderbilt University Medical Center ( Site 3004) Nashville Tennessee 37232 United States Details
UTSW Medical Center ( Site 3003) Dallas Texas 75390-7208 United States Details
Western Sydney Local Health District ( Site 3601) Blacktown New South Wales 2148 Australia Details
St George Hospital ( Site 3602) Kogarah New South Wales 2217 Australia Details
Royal Brisbane and Women s Hospital ( Site 3603) Herston Queensland 4029 Australia Details
Austin Health ( Site 3600) Melbourne Victoria 3084 Australia Details
Princess Margaret Cancer Centre ( Site 3101) Toronto Ontario M5G 1Z5 Canada Details
Jewish General Hospital ( Site 3100) Montreal Quebec H3T 1E2 Canada Details
James Lind Centro de Investigación del Cáncer ( Site 4108) Temuco Araucania 4800827 Chile Details
CIDO SpA-Oncology ( Site 4106) Temuco Araucania 4810148 Chile Details
FALP-UIDO ( Site 4100) Santiago Region M. De Santiago 7500921 Chile Details
Bradfordhill-Clinical Area ( Site 4101) Santiago Region M. De Santiago 8420383 Chile Details
ONCOCENTRO APYS-ACEREY ( Site 4103) Viña del Mar Valparaiso 2520598 Chile Details
Institut De Cancerologie De Lorraine ( Site 3204) Vandoeuvre les Nancy Ain 54519 France Details
Institut de cancérologie Strasbourg Europe (ICANS) ( Site 3203) Strasbourg Alsace 67033 France Details
Institut Claudius Regaud ( Site 3200) Toulouse Cedex 9 Haute-Garonne 31059 France Details
Gustave Roussy ( Site 3202) Villejuif Val-de-Marne 94800 France Details
Országos Onkológiai Intézet-Urogenitális Tumorok és Klinikai Farmakológiai Osztály ( Site 4301) Budapest Pest 1122 Hungary Details
Rambam Health Care Campus-Oncology Division ( Site 3500) Haifa 3109601 Israel Details
Hadassah Medical Center-Oncology ( Site 3504) Jerusalem 9112001 Israel Details
Rabin Medical Center ( Site 3502) Petah Tiqwa 4941492 Israel Details
Sheba Medical Center - Oncology Division ( Site 3501) Ramat Gan 52621 Israel Details
Sourasky Medical Center ( Site 3503) Tel Aviv 6423906 Israel Details
Asan Medical Center ( Site 3800) Songpagu Seoul 05505 Korea, Republic of Details
Severance Hospital ( Site 3802) Seoul 03722 Korea, Republic of Details
Samsung Medical Center ( Site 3801) Seoul 06351 Korea, Republic of Details
Nederlands Kanker Instituut - Antoni van Leeuwenhoek (NKI-AVL)-medical oncology ( Site 4402) Amsterdam Noord-Holland 1066 CX Netherlands Details
Erasmus Medisch Centrum ( Site 4401) Rotterdam Zuid-Holland 3015 GD Netherlands Details
Auckland City Hospital ( Site 3700) Auckland 1023 New Zealand Details
Centrum Onkologii im. Prof. Franciszka Lukaszczyka-Ambulatorium Chemioterapii ( Site 4201) Bydgoszcz Kujawsko-pomorskie 85-796 Poland Details
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Oddzial Badan Wczesnych Faz ( Site 4200 Warszawa Mazowieckie 02-781 Poland Details
Uniwersyteckie Centrum Kliniczne-Early Clinical Trials Unit ( Site 4202) Gdańsk Pomorskie 80-952 Poland Details
Hospital Universitari Vall d Hebron ( Site 3300) Barcelona Cataluna 08035 Spain Details
Hospital Universitario Ramon y Cajal ( Site 3301) Madrid 28034 Spain Details
Southampton General Hospital ( Site 3403) Southampton England SO16 6YD United Kingdom Details
The Beatson West of Scotland Cancer Centre ( Site 3405) Glasgow Glasgow City G12 0YN United Kingdom Details
Royal Preston Hospital ( Site 3406) Preston Lancashire PR2 9HT United Kingdom Details
Leicester Royal Infirmary ( Site 3408) Leicester Leicestershire LE1 5WW United Kingdom Details
Barts Health NHS Trust ( Site 3401) London London, City Of EC1A 7BE United Kingdom Details
Western General Hospital ( Site 3402) Edinburgh Midlothian EH42XU United Kingdom Details
Velindre Cancer Centre Hospital ( Site 3407) Cardiff Wales CF14 2TL United Kingdom Details
The Christie NHS Foundation Trust ( Site 3400) Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field